Literature DB >> 11028581

Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery.

V C Heath1, G Daskalakis, A Zagaliki, M Carvalho, K H Nicolaides.   

Abstract

OBJECTIVES: To establish the prevalence of cervicovaginal fetal fibronectin positivity at 23 weeks of gestation in a routine population of singleton pregnancies and determine the relative risk of spontaneous delivery before 33 weeks in women with a fibronectin positive result.
DESIGN: Prospective clinical study.
SETTING: Inner city antenatal clinic. POPULATION: Singleton pregnancies attending for routine antenatal care.
METHODS: Cervicovaginal fetal fibronectin and cervical length were measured at 23 weeks of gestation. The distribution of fibronectin positivity within subgroups according to maternal characteristics was calculated and the relative risk of spontaneous delivery before 33 weeks was estimated. MAIN OUTCOME MEASURES: Prevalence of a fibronectin positive result and its relation to cervical length measurement and spontaneous preterm delivery before 33 weeks.
RESULTS: Of 5,146 women participating in the study, 182 (3.5%) had a fibronectin positive result and 76 (1.5%) had a cervical length of < 15 mm. Fibronectin positive women were more likely to be Afro-Caribbean in origin, to have had a previous second trimester miscarriage and to have a short cervix. In the 5,068 women who were managed expectantly, the significantly independent relative risk of spontaneous delivery at < 33 weeks was 46.2 (95% CI 18.8-113.6), for cervical length of < or = 15 mm, 8.1 (95% CI 3.8-17.5) for a fibronectin positive result, and 4.4 (95% CI 2.2-9.1) for cigarette smoking.
CONCLUSION: Fibronectin positivity at 23 weeks of gestation provides useful prediction of pregnancies at risk of spontaneous preterm delivery before 33 weeks, with a relative risk that is twice as high as cigarette smoking, but is a sixth of that of cervical length.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028581     DOI: 10.1111/j.1471-0528.2000.tb11620.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  6 in total

Review 1.  Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review.

Authors:  Honest Honest; Lucas M Bachmann; Janesh K Gupta; Jos Kleijnen; Khalid S Khan
Journal:  BMJ       Date:  2002-08-10

Review 2.  Recent developments in obstetrics.

Authors:  Andrew H Shennan
Journal:  BMJ       Date:  2003-09-13

Review 3.  Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data.

Authors:  Roberto Romero; Kypros Nicolaides; Agustin Conde-Agudelo; Ann Tabor; John M O'Brien; Elcin Cetingoz; Eduardo Da Fonseca; George W Creasy; Katharina Klein; Line Rode; Priya Soma-Pillay; Shalini Fusey; Cetin Cam; Zarko Alfirevic; Sonia S Hassan
Journal:  Am J Obstet Gynecol       Date:  2011-12-11       Impact factor: 8.661

4.  A high concentration of fetal fibronectin in cervical secretions increases the risk of intra-amniotic infection and inflammation in patients with preterm labor and intact membranes.

Authors:  Kyung Joon Oh; Roberto Romero; Jee Yoon Park; Jihyun Kang; Joon-Seok Hong; Bo Hyun Yoon
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

5.  Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.

Authors:  S S Hassan; R Romero; D Vidyadhari; S Fusey; J K Baxter; M Khandelwal; J Vijayaraghavan; Y Trivedi; P Soma-Pillay; P Sambarey; A Dayal; V Potapov; J O'Brien; V Astakhov; O Yuzko; W Kinzler; B Dattel; H Sehdev; L Mazheika; D Manchulenko; M T Gervasi; L Sullivan; A Conde-Agudelo; J A Phillips; G W Creasy
Journal:  Ultrasound Obstet Gynecol       Date:  2011-06-15       Impact factor: 7.299

6.  Can preterm labour be predicted in low risk pregnancies? Role of clinical, sonographic, and biochemical markers.

Authors:  Reva Tripathi; Shakun Tyagi; Nilanchali Singh; Yedla Manikya Mala; Chanchal Singh; Preena Bhalla; Siddhartha Ramji
Journal:  J Pregnancy       Date:  2014-10-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.